Biotechnology in Japan

Biotechnology in Japan

Code: ML-OHME4829 | Published: Jan-2016 | Pages: 36 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The Japanese biotechnology market is expected to generate total revenues of $35.6bn in 2015, representing a compound annual growth rate (CAGR) of 3.4% between 2011 and 2015.

- The environment and industrial processing segment is expected to be the markets most lucrative in 2015, with total revenues of $12.2bn, equivalent to 34.3% of the markets overall value.

- The Japanese government has invested significantly in the biotech industry, partly in response to Chinas aim of overtaking Japan as a regional center for the industry. In 2014, the government set aside approximately $165bn for cancer initiatives as well as further investment in the creation of a pilot factory for biologic drugs.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

Leading company profiles reveal details of key biotechnology market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Japan economy

Reasons To Buy
What was the size of the Japan biotechnology market by value in 2015?

What will be the size of the Japan biotechnology market in 2020?

What factors are affecting the strength of competition in the Japan biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Japans biotechnology market?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Astellas Pharma Inc. 19
Daiichi Sankyo Co., Ltd. 22
Mitsubishi Tanabe Pharma Corporation 25
Takeda Pharmaceutical Company Limited 28
Macroeconomic Indicators 31
Country Data 31
Methodology 33
Industry associations 34
Related MarketLine research 34
Appendix 35
About MarketLine 35

List of Tables
Table 1: Japan biotechnology industry value: $ billion, 2011-15(e)
Table 2: Japan biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: Japan biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: Japan biotechnology industry value forecast: $ billion, 2015-20
Table 5: Astellas Pharma Inc.: key facts
Table 6: Astellas Pharma Inc.: key financials ($)
Table 7: Astellas Pharma Inc.: key financials (Yen)
Table 8: Astellas Pharma Inc.: key financial ratios
Table 9: Daiichi Sankyo Co., Ltd.: key facts
Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 11: Daiichi Sankyo Co., Ltd.: key financials (Yen)
Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 13: Mitsubishi Tanabe Pharma Corporation: key facts
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (Yen)
Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: key financials ($)
Table 19: Takeda Pharmaceutical Company Limited: key financials (Yen)
Table 20: Takeda Pharmaceutical Company Limited: key financial ratios
Table 21: Japan size of population (million), 2011-15
Table 22: Japan gdp (constant 2005 prices, $ billion), 2011-15
Table 23: Japan gdp (current prices, $ billion), 2011-15
Table 24: Japan inflation, 2011-15
Table 25: Japan consumer price index (absolute), 2011-15
Table 26: Japan exchange rate, 2011-15

List of Figures
Figure 1: Japan biotechnology industry value: $ billion, 2011-15(e)
Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: Japan biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2015
Figure 11: Astellas Pharma Inc.: revenues and profitability
Figure 12: Astellas Pharma Inc.: assets and liabilities
Figure 13: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 14: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues and profitability
Figure 16: Mitsubishi Tanabe Pharma Corporation: assets and liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues and profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets and liabilities
Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Biotechnology
MarketLine

Our Clients